Fatal outcome of posterior “reversible” encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen
Open Access
- 20 August 2014
- journal article
- case report
- Published by Springer Science and Business Media LLC in World Journal of Surgical Oncology
- Vol. 12 (1), 1-4
- https://doi.org/10.1186/1477-7819-12-264
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adultsClinical Radiology, 2013
- Posterior Reversible Encephalopathy Syndrome: Associated Clinical and Radiologic FindingsMayo Clinic Proceedings, 2010
- Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic EdemaAmerican Journal Of Neuroradiology, 2008
- Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy SyndromeAmerican Journal Of Neuroradiology, 2007
- Reversible Posterior Leukoencephalopathy Syndrome After Bevacizumab/FOLFIRI Regimen for Metastatic Colon CancerArchives of Neurology, 2006
- Reversible posterior leukoencephalopathy syndrome and bevacizumab.2006
- Reversible Posterior Leukoencephalopathy Syndrome and BevacizumabNew England Journal of Medicine, 2006
- Posterior Reversible Encephalopathy Syndrome: Prognostic Utility of Quantitative Diffusion-Weighted MR Images2002
- Posterior leukoencephalopathy syndromePublished by Oxford University Press (OUP) ,2001
- A Reversible Posterior Leukoencephalopathy SyndromeNew England Journal of Medicine, 1996